Skip to main content
. 2016 Sep 30;7:12864. doi: 10.1038/ncomms12864

Figure 8. Human homologue of lnc-MGC and its inhibition by HMGC10 in HMC.

Figure 8

Significant increase of hlnc-MGC (human homologue of lnc-MGC), miR-379, miR-494, miR-495 and miR-377 in human MC (HMC) treated with TGF-β1 (a) or HG (b) compared with respective controls (SD or normal glucose), but not miR-882 (outside of miR-379 cluster). These increases were significantly reduced in HMC transfected with HMGC10 compared with control oligo. (c) HMGC10 mediated restoration of miR-379 cluster targets, EDEM3, ATF3, CUGBP2 and CPEB4 which were inhibited by TGF-β1 in HMC. (d) Significant increase of profibrotic genes, TGF-β1, COL1A2, COL4A1, FN1 and CTGF in HMC treated with TGF-β1 and their significant inhibition in HMC transfected with HMGC10. (e) HMGC10 mediated restoration of miR-379 cluster targets, EDEM3, ATF3, CUGBP2 and CPEB4 which were inhibited by HG in HMC. (f) Significant increase of profibrotic genes, TGF-β1, COL1A2, COL4A1, FN1 and CTGF in HMC treated with HG which was significantly inhibited by HMGC10. Results are mean+s.e. in triplicate PCRs from three independent culture experiments. *P<0.05.